Video

'Connection is Key' in Conversations Between Parents and Children About Ovarian Cancer

Author(s):

Ryan H. Mitstifer Walton

A young advocate emphasizes the importance of communication between parents and their children about an ovarian cancer diagnosis.

Ryan H. Mitstifer Walton, a 16-year-old high school sophomore, has been an ovarian cancer advocate his entire life, volunteering for the National Ovarian Cancer Coalition (NOCC).

At the Ovarian Cancer Heroes event in Honolulu, Hawaii, Walton shared how his mother’s ovarian cancer diagnosis shaped him into the enthusiastic advocate he is today, while also emphasizing the importance of communication parents and their children when it comes to a diagnosis.

“Include us. You are not protecting us by your silence,” said Walton. “We know when something is wrong. Tell us your fears and let us know how we can help.”

Newsletter

Stay up to date on cancer updates, research and education

Subscribe Now!
Related Videos
Image of Dr. Boffa.
Immune Therapy Expands Melanoma Treatment to More Patients
Bladder preservation for bladder cancer requires balancing clinical factors and patient health with a personalized treatment plan.
image of doctor D'Sa
Image of Dr. Eng.
Image of Dr. Tagawa.
Most patients in accredited hospitals had smoking discussions documented, showing key care opportunities and smoking’s impact on treatment outcomes.
Illustration of doctor.
Image of doctor.
Image of man with black hair.
Related Content
Image of ovary.
May 8th 2025

The OVATION 3 Study Initiates First Trial Site for Ovarian Cancer

Ryan Scott
The first trial site has been initiated in the pivotal phase 3 OVATION 3 study which will investigate IMNN-001 for newly diagnosed advanced ovarian cancer.
cancer horizons logo: a white microphone on a navy blue background
March 11th 2024

Oncology Approvals, Psychological Outcomes for Survivors and an Ovarian Cancer Vaccine

Alex Biese Brielle Benyon
Last week we saw some FDA approvals come through, as well as research that explored the psychosocial outcomes of individuals who survived pediatric rhabdosarcoma.
Kelly Irvin was diagnosed with stage 4 ovarian cancer in January 2016. Catch up on all of Kelly's blogs here!
May 6th 2025

Nurse’s Big Personality Makes Cancer Treatment More Bearable.

Kelly Irvin
She wore a variety of bright sneakers and occasionally did a cha-cha-cha in them. Her laughter was contagious. Patients smiled. The other nurses smiled.
Shannon Miller smiling at a podium while delivering the keynote address at the 2023 Extraordinary Healer event | Image credit: © ATA-GIRL PHOTOGRAPHY
May 4th 2023

Olympian Shares Her Cancer Experience: ‘Give Yourself Grace’

Brielle Benyon
Olympic gymnast, Shannon Miller, sat down with CURE® to discuss her experience with a rare type of ovarian cancer, and how her competitive mindset helped her through.
INX-315 received FDA fast track designation for patients with CCNE1-amplified platinum-resistant ovarian cancer: © stock.adobe.com.
April 29th 2025

FDA Fast Tracks INX-315 for Tough-to-Treat Ovarian Cancer

Spencer Feldman
INX-315, a CDK2 inhibitor, received FDA fast track designation for patients with CCNE1-amplified platinum-resistant ovarian cancer.
CURE spoke with Dr. Michael K. Wong and Dr. Diwakar Davar about the use of ctDNA for patients with melanoma, and where the field may be headed.
April 11th 2025

What Role May ctDNA Have in Melanoma Management?

Dr. Michael K. Wong
CURE spoke with Dr. Michael K. Wong and Dr. Diwakar Davar about the use of ctDNA for patients with melanoma, and where the field may be headed.